Vanessa Duarte

Background Preeclampsia (PE) is a leading cause of maternal and perinatal morbimortality, particularly in low- and middle-income countries. Despite advances in clinical management, its etiology and pathogenesis remain unclear, and effective predictive biomarkers are lacking.

1. Introduction The severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), responsible for the lung disease called COVID-19, was first identified in December 2019 in China [1]. Since its discovery, SARS-CoV-2 has rapidly spread worldwide, leading to a global pandemic state declared by the World Health Organization (WHO) in March 2020 [2].